Michael T. Sember
CIK: 0001107486
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Quoin Pharmaceuticals, Ltd.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Feb 4, 2026QNRX
Quoin Pharmaceuticals, Ltd.
Award(A)DirectShare Option (Right to Buy)
8.1K shares- - May 29, 2025QNRX
Quoin Pharmaceuticals, Ltd.
Award(A)DirectShare Option (Right to Buy)
7.8K shares- - Dec 9, 2024QNRX
Quoin Pharmaceuticals, Ltd.
Award(A)DirectShare Option (Right to Buy)
50.7K shares-
1-3 of 3 transactions
About SEMBER MICHAEL T
SEMBER MICHAEL T (SEC CIK 0001107486) files insider reports with the SEC as Director of Quoin Pharmaceuticals, Ltd. (QNRX).
Signal8 holds 3 ownership filings by SEMBER MICHAEL T, all Form 4s, filed between Dec 10, 2024 and Feb 6, 2026. Those filings report 3 transactions, from Dec 9, 2024 to Feb 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on SEMBER MICHAEL T's filings is in ASHBURN, VA.
Recent filings by SEMBER MICHAEL T
Other insiders filing for Quoin Pharmaceuticals, Ltd. (QNRX)
- LANGER DENNIS, Director
- Carter Denise P., Chief Operating Officer
- Myers Michael, Chief Executive Officer
- Lawlor Sally Bridget, Chief Financial Officer
- Culverwell Anthony James, Director
- Cooper Joseph Patrick, Director